Estimation of NLRP3 Inflammasome Role and some Biochemical Parameters in Patients with Chronic Kidney Diseases (CKD)
DOI:
https://doi.org/10.32792/utq/utjsci/v10i2.1063Keywords:
Chronic Kidney Disease , NLRP3 inflammasome , Inflammation marker and kidney function tests. .Abstract
Chronic kidney disease (CKD) is a widespread condition that poses a major threat to human health. With substantial public health costs, severe morbidity, and mortality, CKD prevalence is increasing. The study aimed to look at NLRP3 inflammasome , hsCRP , Urea , Creatinine, Uric acid and GFR levels. Serum NLRP3 inflammasome , hsCRP , Urea , Creatinine, Uric acid and GFR levels were determined in 90 patients with Chronic Kidney Diseases (CKD) , and 85 healthy subjects, an age range (30-75). The results of current study show a significant increase in the concentration of serum NLRP3 inflammasome, hs-CRP, urea , creatinine and uric acid in (CKD) patients group in comparison with controls group (p<0.05). While shows a significant decrease in GRF in (CKD) patients group in comparison with controls group (p<0.05). The aim of this study is estimated the NLRP3 inflammasome , Inflammation marker , kidney function tests and Glomerular filtration rate (GFR) in patients with Chronic Kidney Disease.
Received: 2023-06-15
Revised: 2023-07-02
Accepted: 2023-07-02
References
C.E. Amadi, A.C. Mbakwem, O.A. Kushimo, et al. Prevalence of positive chronic kidney Disease screening in professional male long haul drivers at risk of cardiovascular Disease in Lagos, Nigeria: a cross-section study. BMC Publ. Health. ;19:1032, 2019.
R.F. Al, D. Stewart, F .Fernandez-Llimos, et al. Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review. Int. J. Clin. Pharm. ;41:630–666, 2019.
L. Zhang, F. Wang, L. Wang, et al. Prevalence of chronic kidney disease in China:a cross-sectional survey. Lancet. ;379:815–822, 2012.
C.C. Kuo, C.M. Chang, K.T. Liu, et al. Automation of the kidney function prediction and classification through ultrasound-based kidney imaging using deep learning. NPJ Digit Med. ;2:29, 2019.
A. M. Cusumano, C. Tzanno-Martins, and G. J. Rosa-Diez. The glomerular filtration rate: from the diagnosis of kidney function to a public health tool. Frontiers in Medicine, 8, 769335, 2021.
A. R. Sehgal. Race and the false precision of glomerular filtration rate estimates. Annals of Internal Medicine, 173(12), 1008-1009, 2020.
R.G. Nelson, M.E. Grams, S.H. Ballew, et al. Development of risk prediction equations for incident chronic kidney disease JAMA, 322, pp. 2104-2114 , 2019.
J. Jitraknatee, , C. Ruengorn, , and S. Nochaiwong. Prevalence and risk factors of chronic kidney disease among type 2 diabetes patients: a cross-sectional study in primary care practice. Scientific reports, 10(1), 6205, 2020.
M. C. Dessing, , J. Kers, , J. Damman, , G. J. Navis , S. Florquin, , and J. C. Leemans. Donor and recipient genetic variants in NLRP3 associate with early acute rejection following kidney transplantation. Scientific Reports, 6(1), 36315, 2016.
C. M. Artlett. The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis. Biomolecules, 12(5), 634, 2022.
G. Yu, Z. Bai, Z. Chen, H. Chen, G. Wang, G. Wang, and Z. Liu. The NLRP3 inflammasome is a potential target of ozone therapy aiming to ease chronic renal inflammation in chronic kidney disease. International immunopharmacology, 43, 203-209, 2017.
Y. Liu, H. Chen, Y. H. Ko, C. H. Kuo, C. W. Yen, C. C. Chen, W. ... and C. M. Chen. SOD3 and IL-18 Predict the First Kidney Disease-Related Hospitalization or Death during the One-Year Follow-Up Period in Patients with End-Stage Renal Disease. Antioxidants, 11(6), 1198, 2022.
Z.A. Massy, C .Pietrement, and F .Touré. Reconsidering the lack of urea toxicity in dialysis patients. Semin Dial; 29: 333–337, 2016.
Y. Zuo, C .Wang, J .Zhou, A. Sachdeva, and V.C. Ruelos. Simultaneous determination of creatinine and uric acid in human urine by high-performance liquid chromatography. Anal Sci. Dec;24(12):1589-92, 2008.
B .Bonino, G. Leoncini , E. Russo, R. Pontremoli, and F. Viazzi. Uric acid in CKD: has the jury come to the verdict? J Nephrol. 33:715–24, 2020.
D.W. Moss, A.R. Henderson, and J.F. Kachmar. Enzymes In: Fundamentals of clinical chemistry 3rd ed n. Tietz, NW Ed. Philadelphia, WB Saunders Company; 1987.
O. S. El‐Deeb, , M. M. Atef, , and Y. M. Hafez. The interplay between microbiota‐dependent metabolite trimethylamine N‐oxide, Transforming growth factor β/SMAD signaling and inflammasome activation in chronic kidney disease patients: A new mechanistic perspective. Journal of Cellular Biochemistry, 120(9), 14476-14485, 2019.
C. Ying, Z. Zhou, J. Dai, et al. Activation of the NLRP3 inflammasome by RAC1 mediates a new mechanism in diabetic nephropathy. Inflamm. Res. ;71:191–204, 2022.
H. Guo, J.B. Callaway, and J.P. Ting -Y. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. ;21:677–687, 2015.
J .Gupta, N . Mitra, P.A. Kanetsky, J Devaney, M.R. Wing, M. Reilly, V.O. Shah, V.S. Balakrishnan, N.J. Guzman, M .Girndt, et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol. ; 7:1938–1946, 2012.
P. Muntner, J . He, L .Hamm, C. Loria, and P.K. Whetton. Renal insufficiency and subsequent death from cardiovascular disease. J AM Soc Nephrol.;13:745-53, 2002.
CKD registry of India: Indian Society of Nephrology. Available from http://www.ckdri.org [Accessed September, 2012.
M.J. Sarnak et al. Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal disease study. Kidney International;62:2208-2215, 2002.
I.A. Sirwal , K.A. Banday, A.R. Reshi, M.A. Bhat,. and M.M. Wani . Estimation of Glomerular Filteration Rate (GFR). JK Science. 6: 121-123, 2004.
R.D. Perrone, Madias and N.E. Levey. Serum creatinine as index of renal function. Clin. Chem. 38: 1933-1953, 1992.
A. Mittal, B. Sathian, A. Kumar, N . Chandrasekharan, and A. Sunka . Diabetes mellitus as a potential risk factor for renal disease among napalese: A hospital based case control study. NJE.;1(1):22-25, 2010.
Z .Shaymaa. , S. Ahmed, T .Rana, and R. Baida. Fasting sugar, blood pressure and uric acid are factors related to positive Kidney disease and an impaired GFR. University of Thi-Qar Journal of Science (UTJsci). ISSN Print: 1991-8690, (9),.2, 2022.
D.E. Weiner, H. Tighiouart, E.F. Elsayed, J.L. Griffith, D.N. Salem, and A.S. Levey. Uric acid and incident kidney disease in the community. J Am Soc Nephrol;19(6):1204–1211. 2008.
C.Y. Hsu, C. Iribarren, C.M., J.D., and A.G. Risk Factors for End-Stage Renal Disease: 25 year Follow-up. Arch Intern Med;169(4):342–350. 2009.
E. Krishnan, K.S. Akhras, H. Sharma, M. Marynchenko, E .Wu, R.H. Tawk, et al. Serum urate and incidence of kidney disease among veterans with gout. J Rheumatol ;40(7):1166–1172. 2013.
L.H. Ficociello, E.T. Rosolowsky, M.A. Niewczas, N.J. Maselli, J.M. Weinberg, A. Aschengrau, et al. High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care ;33(6):1337–1343. 2010.
A. Ishani, G.A. Grandits, R.H. Grimm, K.H. Svendsen, A.J. Collins, R.J. Prineas, et al. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol;17(5):1444–1452 , 2006.
Downloads
Published
License
Copyright (c) 2023 University of Thi-Qar Journal of Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
